See more : BTL Inc. (6840.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Columbia Care Inc. (CCHWF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Columbia Care Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Zhejiang Gongdong Medical Technology Co.,Ltd. (605369.SS) Income Statement Analysis – Financial Results
- Spirit of Texas Bancshares, Inc. (STXB) Income Statement Analysis – Financial Results
- Tansun Technology Co., Ltd. (300872.SZ) Income Statement Analysis – Financial Results
- Qatar Industrial Manufacturing Company Q.P.S.C. (QIMD.QA) Income Statement Analysis – Financial Results
- Asefa Public Company Limited (ASEFA.BK) Income Statement Analysis – Financial Results
Columbia Care Inc. (CCHWF)
About Columbia Care Inc.
Columbia Care Inc. cultivates, manufactures, and provides cannabis products and related services. It offers flowers, edibles, oils, and tablets under the Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD brands. The company holds licenses in 18 jurisdictions in the United States and the European Union. As of June 15, 2022, it operated 131 facilities, including 99 dispensaries and 32 cultivation and manufacturing facilities. The company was founded in 2012 and is headquartered in New York, New York.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 511.58M | 460.08M | 179.50M | 77.46M | 0.00 |
| Cost of Revenue | 310.37M | 266.07M | 113.53M | 40.60M | 0.00 |
| Gross Profit | 201.21M | 194.02M | 65.98M | 36.86M | 0.00 |
| Gross Profit Ratio | 39.33% | 42.17% | 36.76% | 47.59% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 203.69M | 179.48M | 118.34M | 105.44M | 0.00 |
| Selling & Marketing | 14.17M | 16.26M | 6.08M | 5.79M | 0.00 |
| SG&A | 617.45M | 195.73M | 124.42M | 111.24M | 0.00 |
| Other Expenses | -16.45M | 36.32M | 15.65M | 7.45M | 0.00 |
| Operating Expenses | 617.45M | 232.05M | 140.07M | 118.68M | 0.00 |
| Cost & Expenses | 927.82M | 498.12M | 253.60M | 159.28M | 0.00 |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 53.90M | 30.01M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 84.79M | 53.00M | 42.02M | 26.26M | 161.14K |
| EBITDA | -416.24M | 13.64M | -32.08M | -55.56M | 0.00 |
| EBITDA Ratio | -81.36% | 2.96% | -17.87% | -71.73% | 0.00% |
| Operating Income | -416.24M | -39.37M | -74.10M | -81.82M | 0.00 |
| Operating Income Ratio | -81.36% | -8.56% | -41.28% | -105.63% | 0.00% |
| Total Other Income/Expenses | -16.45M | -107.35M | -62.77M | -12.04M | 0.00 |
| Income Before Tax | -432.69M | -146.71M | -136.87M | -93.85M | 0.00 |
| Income Before Tax Ratio | -84.58% | -31.89% | -76.25% | -121.17% | 0.00% |
| Income Tax Expense | -11.21M | 139.00K | -3.67M | 12.87M | 0.00 |
| Net Income | -421.48M | -146.85M | -133.20M | -106.73M | 0.00 |
| Net Income Ratio | -82.39% | -31.92% | -74.20% | -137.79% | 0.00% |
| EPS | -1.16 | -0.43 | -0.57 | -0.51 | 0.00 |
| EPS Diluted | -1.16 | -0.43 | -0.57 | -0.51 | 0.00 |
| Weighted Avg Shares Out | 363.17M | 338.75M | 232.58M | 209.99M | 209.99M |
| Weighted Avg Shares Out (Dil) | 363.17M | 338.75M | 232.58M | 209.99M | 209.99M |
Columbia Care Reports Second Quarter 2023 Results
NEW YORK--(BUSINESS WIRE)--Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today reported its financial and operating results...
This Mega Cannabis Merger Has Fallen Through: Is M&A in Cannabis Dead?
Cresco Labs and Columbia Care announced in March 2022 that they would be merging. Cannabis stocks have struggled mightily since then, however.
Columbia Care Continues Virginia Expansion with Opening of Cannabist Suffolk
NEW YORK--(BUSINESS WIRE)--Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced it has opened the doors...
CSE Bulletin: Delist - Columbia Care Inc. (CCHW)
Toronto, Ontario--(Newsfile Corp. - le 1 août/August 2023) -The common shares of Columbia Care Inc. will be delisted from the CSE at market close on August 2, 2023. The common shares will continue to trade on Cboe Canada.
Columbia Care Announces Date for Voluntary Delisting of Common Shares from CSE
NEW YORK--(BUSINESS WIRE)--Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced that, further to...
Columbia Care to Report Second Quarter 2023 Results on August 14, 2023
NEW YORK--(BUSINESS WIRE)--Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced that it will report its financial results for the second quarter ended June 30, 2023 before U.S. financial markets open...
Cannabis companies Cresco, Columbia call off $2 billion merger as industry awaits banking reform
The termination comes as the cannabis industry struggles to scale as it awaits crucial federal and banking reform.
Cresco Labs and Columbia Care call off $2B merger
Cannabis companies Cresco Labs and Columbia Care announced Monday that their $2 billion merger which was announced in March last year has been amicably terminated. Cresco Labs CEO Charles Bachtell said the decision was made to serve the long-term interest...
Cresco Labs, Columbia Care scrap merger announced in March, 2022
Cresco Labs CRLBF, +0.25% CL, stock was down 1.6% in premarket trading Monday after the cannabis company said it mutually agreed to terminate its merger agreement with Columbia Care CCHWF, +0.02% after the two companies initially announced the deal in...
Columbia Care Announces Corporate Actions to Accelerate Operational Efficiencies and Cash Flow Generation
NEW YORK--(BUSINESS WIRE)--Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today provided additional corporate updates...
Source: https://incomestatements.info
Category: Stock Reports